Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Sodium-dependent noradrenaline transporter | ||
Ligand | BDBM50365330 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_806517 (CHEMBL1959650) | ||
IC50 | 4400±n/a nM | ||
Citation | Annedi, SC; Ramnauth, J; Maddaford, SP; Renton, P; Rakhit, S; Mladenova, G; Dove, P; Silverman, S; Andrews, JS; Felice, MD; Porreca, F Discovery of cis-N-(1-(4-(methylamino)cyclohexyl)indolin-6-yl)thiophene-2-carboximidamide: a 1,6-disubstituted indoline derivative as a highly selective inhibitor of human neuronal nitric oxide synthase (nNOS) without any cardiovascular liabilities. J Med Chem55:943-55 (2012) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Sodium-dependent noradrenaline transporter | |||
Name: | Sodium-dependent noradrenaline transporter | ||
Synonyms: | Monoamine transporter | NAT1 | NET | NET1 | Noradrenaline Transporter (NET) | Norepinephrine Transporter (NET) | Norepinephrine transporter protein (NET) | SC6A2_HUMAN | SLC6A2 | SLC6A5 | Sodium-dependent noradrenaline transporter (NET) | Solute carrier family 6 member 2 | ||
Type: | Multi-pass membrane protein | ||
Mol. Mass.: | 69337.72 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P23975 | ||
Residue: | 617 | ||
Sequence: |
| ||
BDBM50365330 | |||
n/a | |||
Name | BDBM50365330 | ||
Synonyms: | CHEMBL1956107 | ||
Type | Small organic molecule | ||
Emp. Form. | C20H26N4S | ||
Mol. Mass. | 354.512 | ||
SMILES | CN[C@H]1CC[C@H](CC1)N1CCc2ccc(cc12)N=C(N)c1cccs1 |r,w:17.19,wD:5.8,2.1,(9.98,-4.84,;11.31,-4.07,;11.31,-2.53,;12.65,-1.76,;12.65,-.21,;11.31,.55,;9.98,-.22,;9.98,-1.76,;11.32,2.09,;12.23,3.35,;11.32,4.6,;9.84,4.12,;8.51,4.88,;7.18,4.11,;7.18,2.57,;8.51,1.8,;9.84,2.57,;5.84,1.8,;4.51,2.57,;4.51,4.11,;3.18,1.8,;1.77,2.44,;.74,1.29,;1.51,-.04,;3.02,.28,)| | ||
Structure |